Role of antiseptic barrier caps in CLABSI reduction
"There was a 68% reduction in CLABSI events. By the end of 2024, the unit achieved a CLABSI standardized infection ratio of 0.414, representing a substantial improvement compared to the 2023 ratio of 1.45. The cost avoidance from ABC implementation was about $320,787. CLABSI reduction was sustained in 2025, and ABCs were implemented on the hematology-oncology unit" Rowland Rutledge et al (2026).